• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Coronary CT angiography superior to functional stress testing among diabetic patients

byJalal EbrahimandAnees Daud
March 4, 2019
in Cardiology, Emergency, Endocrinology, Imaging and Intervention
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this randomized trial, diabetic patients with stable chest pain randomized to coronary computed tomographic angiography (CTA) had lower rates of cardiovascular death and myocardial infarction than those randomized to functional stress testing.

2. This benefit of the coronary CTA was not seen in nondiabetic patients.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Diabetes is one of the most common chronic diseases and a well-established cardiovascular risk factor. There has not been compelling data on an investigative strategy for diabetic patients with chest pain. In this randomized trial using data from PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain), diabetic patients randomized to coronary CTA compared with functional stress testing (nuclear imaging/stress echocardiogram/stress ECG) had lower rates of the composite outcome of cardiovascular death and myocardial infarction. This effect was not seen in non-diabetic patients. There was no difference in the composite outcome of death, myocardial infarction, and unstable angina hospitalization for diabetic or non-diabetic patients, although there was a trend towards improved outcome for diabetic patients randomized to coronary CTA for this outcome.

Although the randomized nature of this study and relatively balanced groups supports its conclusion, there are several limitations. Firstly, the sample size was small, with fewer than 2000 diabetic patients included in the final analysis. Secondly, 14% of the sample in the functional stress testing group and 9% of the sample in the coronary CTA group were lost to follow up.

Click to read the study in JACC

Relevant Reading: Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease

RELATED REPORTS

#VisualAbstract: CT associated with lower complication risks than invasive coronary angiography

Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events

Improved mortality rates for myocardial infarction, stroke, and pulmonary embolism in patients receiving dialysis between 1998 to 2015

In-Depth [ randomized controlled trial]: This study used data from PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain), a randomized trial evaluating coronary CTA versus functional stress testing in patients without known coronary disease who had symptoms consistent with stable coronary artery disease (CAD). Total sample size was 8,966 (1,908 with diabetes [21%] and 7,058 without [79%]). Median follow up was 25 months. Patients were randomized to coronary CTA or functional stress testing, which was the treating physician’s choice between exercise ECG, stress nuclear imaging, or stress echocardiogram. Inclusion criteria were age >55 for men or >65 for women, or age 45-54 with 1+ cardiovascular risk factor for men or age 55-64 with 1+ cardiovascular risk factor for women. Exclusion criteria included known history of CAD, non-interpretable non-invasive testing (NIT), unstable chest pain, or congenital/valvular/cardiomyopathic heart disease. Clinical outcomes of interest included time to death/myocardial infarction (MI)/unstable angina hospitalization (UAH) as well as cardiovascular death/MI. Patients with diabetes had similar demographics however more cardiovascular risk factors (hypertension, dyslipidemia, elevated body mass index (BMI)) compared with patients without diabetes.

Patients with diabetes had a higher rate of positive NIT compared to those without diabetes (15.2% vs 11.5%, adjusted OR 1.38, 95% CI 1.19 – 1.60, p<.001). This was consistent across all types of NIT. Of the 972 diabetic patients randomized to functional stress testing, 711 (73%) had nuclear scans, 185 (19%) had stress echocardiograms, and 76 (8%) had stress ECG. Patients randomized to coronary CTA had higher rates of referral to invasive coronary angiography as well as revascularization independent of diabetes status. Patients with diabetes had higher rates of death/MI/UAH (aHR 1.40, 95% CI 1.07-1.83, p=0.015) but similar risk of cardiovascular death/MI (aHR 1.35, 95% CI 0.91-1.99, p=0.131). Among patients with diabetes, those who underwent coronary CTA had non-significantly lower rates of death/MI/UAH (3.4% vs 4.4%, aHR 0.74, 95% CI 0.47 – 1.18, p=0.207) and significantly lower rates of cardiovascular death/MI (1.1% vs 2.6%, aHR 0.38, 95% CI 0.18-0.79, p=0.01).

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chest paincomputed tomography angiography (CTA)diabetes mellitusmyocardial infarction
Previous Post

Patient-centered transitional care services unlikely to benefit hospitalized heart failure patients

Next Post

Danish study finds no association between MMR vaccine and autism, even within high-risk subgroups

RelatedReports

#VisualAbstract: CT associated with lower complication risks than invasive coronary angiography
StudyGraphics

#VisualAbstract: CT associated with lower complication risks than invasive coronary angiography

June 1, 2022
FDA-approved weight loss medications associated with weight loss at one year
Cardiology

Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events

May 25, 2022
Fish oil and aspirin did not reduce arteriovenous fistula failure: The FAVOURED trail
Cardiology

Improved mortality rates for myocardial infarction, stroke, and pulmonary embolism in patients receiving dialysis between 1998 to 2015

April 22, 2022
Nonpowder gun-related pediatric eye injuries on the rise
Cardiology

Ophthalmologic procedures are not associated with increased risk for acute myocardial infarction

April 22, 2022
Next Post
Significant percentage of pediatricians dismiss families who refuse vaccines

Danish study finds no association between MMR vaccine and autism, even within high-risk subgroups

2 Minute Medicine Rewind March 4, 2019

2 Minute Medicine Rewind March 4, 2019

Study reveals suburban clinicians’ perspectives on screening for food insecurity

Social media marketing increases children’s consumption of unhealthy, but not healthy snacks

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Relugolix combination therapy is efficacious for endometriosis-associated pain
  • Age-based products and longer interdose intervals may reduce the risk of cardiac disease following COVID-19 mRNA vaccination
  • OPTN and UNOS update policy regarding hepatocellular carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.